Clinical Trials Browser

Unknown × Locally Advanced Rectal Cancer × Immune Checkpoint Inhibitors × Clear all

NCT05845268 2023-05-06

Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer

Phase 2 Unknown

Gastrointestinal

Locally Advanced Rectal Cancer